DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection-Reference-Cited by-同舟云学术

DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection

Published:2015-12-18 Issue:2 Volume:63 Page:418-427
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Burza Maria Antonella¹,Motta Benedetta Maria¹,Mancina Rosellina Margherita¹,Pingitore Piero¹,Pirazzi Carlo¹,Lepore Saverio Massimo²,Spagnuolo Rocco³,Doldo Patrizia³,Russo Cristina²,Lazzaro Veronica²,Fischer Janett⁴,Berg Thomas⁴,Aghemo Alessio⁵,Cheroni Cristina⁶,De Francesco Raffaele⁶,Fargion Silvia⁷,Colombo Massimo⁵⁷,Datz Christian⁸,Stickel Felix⁹,Valenti Luca⁷,Romeo Stefano¹²¹⁰

Affiliation:

1. Department of Molecular and Clinical Medicine, Sahlgrenska AcademyUniversity of GothenburgGothenburg Sweden

2. Clinical Nutrition Unit, Department of Medical and Surgical SciencesMagna Graecia UniversityCatanzaro Italy

3. Department of Experimental and Clinical MedicineMagna Graecia UniversityCatanzaro Italy

4. Department of Gastroenterology and Rheumatology, Section of HepatologyUniversity HospitalLeipzig Germany

5. Department of GastroenterologyFondazione IRCCS Ca' Granda Ospedale Policlinico MilanoMilan Italy

6. Virology ProgramINGM‐Istituto Nazionale di Genetica Molecolare “Romeo ed Enrica Invernizzi”Milan Italy

7. Università degli Studi di Milano, Fondazione IRCCS Ca'Granda Ospedale Policlinico Milano, Department of Pathophysiology and TransplantationMilan Italy

8. Department of Internal Medicine, Hospital OberndorfTeaching Hospital of the Paracelsus Private University of SalzburgOberndorf Austria

9. Department of Gastroenterology and HepatologyUniversity Hospital of Zürich, Rämistrasse 100, CH‐8091Zürich Switzerland

10. Department of CardiologySahlgrenska University HospitalGothenburg Sweden

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.28322

Reference42 articles.

1. Evolving epidemiology of hepatitis C virus

2. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients